Literature DB >> 21785996

Pathogenesis of the tauopathies.

Michel Goedert1, Maria Grazia Spillantini.   

Abstract

Microtubule-associated protein tau is the most commonly misfolded protein in human neurodegenerative diseases, where it becomes hyperphosphorylated and filamentous. Mutations in MAPT, the tau gene, cause approximately 5% of cases of frontotemporal dementia. They are frequently accompanied by parkinsonism. The existence of MAPT mutations has established that dysfunction of tau protein is sufficient to cause neurodegeneration and dementia. However, most tauopathies are not inherited in a dominant manner. The hyperphosphorylated sites are similar between diseases, but filament morphologies and tau isoform compositions vary. This is consistent with the existence of multiple tau conformers and recent findings have provided experimental support for this concept.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785996     DOI: 10.1007/s12031-011-9593-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  64 in total

1.  Tau is a candidate gene for chromosome 17 frontotemporal dementia.

Authors:  P Poorkaj; T D Bird; E Wijsman; E Nemens; R M Garruto; L Anderson; A Andreadis; W C Wiederholt; M Raskind; G D Schellenberg
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

Review 2.  Tau pathology and future therapeutics.

Authors:  I Gozes
Journal:  Curr Alzheimer Res       Date:  2010-12       Impact factor: 3.498

3.  Significant association between the tau gene A0/A0 genotype and Parkinson's disease.

Authors:  P Pastor; M Ezquerra; E Muñoz; M J Martí; R Blesa; E Tolosa; R Oliva
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

4.  Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22.

Authors:  K C Wilhelmsen; T Lynch; E Pavlou; M Higgins; T G Nygaard
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

5.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

Authors:  M Goedert; C M Wischik; R A Crowther; J E Walker; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

6.  Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.

Authors:  M Hutton; C L Lendon; P Rizzu; M Baker; S Froelich; H Houlden; S Pickering-Brown; S Chakraverty; A Isaacs; A Grover; J Hackett; J Adamson; S Lincoln; D Dickson; P Davies; R C Petersen; M Stevens; E de Graaff; E Wauters; J van Baren; M Hillebrand; M Joosse; J M Kwon; P Nowotny; L K Che; J Norton; J C Morris; L A Reed; J Trojanowski; H Basun; L Lannfelt; M Neystat; S Fahn; F Dark; T Tannenberg; P R Dodd; N Hayward; J B Kwok; P R Schofield; A Andreadis; J Snowden; D Craufurd; D Neary; F Owen; B A Oostra; J Hardy; A Goate; J van Swieten; D Mann; T Lynch; P Heutink
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

7.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Authors:  Amanda J Myers; Alan M Pittman; Alice S Zhao; Kristen Rohrer; Mona Kaleem; Lauren Marlowe; Andrew Lees; Doris Leung; Ian G McKeith; Robert H Perry; Chris M Morris; John Q Trojanowski; Christopher Clark; Jason Karlawish; Steve Arnold; Mark S Forman; Vivianna Van Deerlin; Rohan de Silva; John Hardy
Journal:  Neurobiol Dis       Date:  2006-12-15       Impact factor: 5.996

8.  Genome-wide association study reveals genetic risk underlying Parkinson's disease.

Authors:  Javier Simón-Sánchez; Claudia Schulte; Jose M Bras; Manu Sharma; J Raphael Gibbs; Daniela Berg; Coro Paisan-Ruiz; Peter Lichtner; Sonja W Scholz; Dena G Hernandez; Rejko Krüger; Monica Federoff; Christine Klein; Alison Goate; Joel Perlmutter; Michael Bonin; Michael A Nalls; Thomas Illig; Christian Gieger; Henry Houlden; Michael Steffens; Michael S Okun; Brad A Racette; Mark R Cookson; Kelly D Foote; Hubert H Fernandez; Bryan J Traynor; Stefan Schreiber; Sampath Arepalli; Ryan Zonozi; Katrina Gwinn; Marcel van der Brug; Grisel Lopez; Stephen J Chanock; Arthur Schatzkin; Yikyung Park; Albert Hollenbeck; Jianjun Gao; Xuemei Huang; Nick W Wood; Delia Lorenz; Günther Deuschl; Honglei Chen; Olaf Riess; John A Hardy; Andrew B Singleton; Thomas Gasser
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

9.  Oskar Fischer and the study of dementia.

Authors:  Michel Goedert
Journal:  Brain       Date:  2008-10-24       Impact factor: 13.501

10.  Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.

Authors:  Jana Vandrovcova; Alan M Pittman; Elke Malzer; Patrick M Abou-Sleiman; Andrew J Lees; Nicholas W Wood; Rohan de Silva
Journal:  Neurobiol Aging       Date:  2007-12-26       Impact factor: 4.673

View more
  51 in total

Review 1.  Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis.

Authors:  M T Gentile; M G Reccia; P P Sorrentino; E Vitale; G Sorrentino; A A Puca; L Colucci-D'Amato
Journal:  Mol Neurobiol       Date:  2012-05-31       Impact factor: 5.590

Review 2.  Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease.

Authors:  Yanina Ivashko Pachima; Liu-yao Zhou; Peng Lei; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02       Impact factor: 3.444

3.  Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.

Authors:  Yohei Shibuya; Zhaoyang Niu; Elena Y Bryleva; Brent T Harris; Stephanie R Murphy; Alireza Kheirollah; Zachary D Bowen; Catherine C Y Chang; Ta-Yuan Chang
Journal:  Neurobiol Aging       Date:  2015-04-07       Impact factor: 4.673

Review 4.  Chronic effects of mild neurotrauma: putting the cart before the horse?

Authors:  Rudy J Castellani; George Perry; Grant L Iverson
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

5.  Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.

Authors:  Lina Adwan; Gehad M Subaiea; Riyaz Basha; Nasser H Zawia
Journal:  J Neurochem       Date:  2014-10-18       Impact factor: 5.372

Review 6.  Neuroinflammatory responses in Alzheimer's disease.

Authors:  Cira Dansokho; Michael Thomas Heneka
Journal:  J Neural Transm (Vienna)       Date:  2017-12-22       Impact factor: 3.575

7.  Familial behavioral variant frontotemporal dementia associated with astrocyte-predominant tauopathy.

Authors:  Isidre Ferrer; Andrea Legati; J Carlos García-Monco; Marian Gomez-Beldarrain; Margarita Carmona; Rosa Blanco; William W Seeley; Giovanni Coppola
Journal:  J Neuropathol Exp Neurol       Date:  2015-04       Impact factor: 3.685

Review 8.  Friend or foe-Post-translational modifications as regulators of phase separation and RNP granule dynamics.

Authors:  Mario Hofweber; Dorothee Dormann
Journal:  J Biol Chem       Date:  2018-12-26       Impact factor: 5.157

Review 9.  The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.

Authors:  Peter T Nelson; Erin L Abner; Ela Patel; Sonya Anderson; Donna M Wilcock; Richard J Kryscio; Linda J Van Eldik; Gregory A Jicha; Zsombor Gal; Ruth S Nelson; Bela G Nelson; Jozsef Gal; Md Tofial Azam; David W Fardo; Matthew D Cykowski
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

10.  Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.

Authors:  Elyse Rosa; Sujeivan Mahendram; Yazi D Ke; Lars M Ittner; Stephen D Ginsberg; Margaret Fahnestock
Journal:  Neurobiol Aging       Date:  2016-08-31       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.